Dr. Hemal H. Kadakia, MD

Dr. Kadakia practices at La Palma Intercommunity Hospital in La Palma, California, part of Prime Healthcare Services.

Dr. Kadakia's NPI, 1588686042, was assigned on July 24, 2006. Dr. Kadakia graduated from Rural Medical College Pravara Institute of Medical Sciences in 1999. Dr. Kadakia holds California license A89218.

Dr. Kadakia's primary practice is La Palma Intercommunity Hospital, at 7901 Walker Street, La Palma, CA 90623 in Orange County. The practice phone is (714) 670-7400.

Dr. Kadakia's primary practice is La Palma Intercommunity Hospital in La Palma, California, part of Prime Healthcare Services. Dr. Kadakia is also affiliated with Dignity Health - St. Mary Medical Center. The medical group on file is Signify Health. Dmand AI also links Dr. Kadakia to 3 more hospitals, 9 medical groups, 3 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadakia practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kadakia's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kadakia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kadakia's licenses on file in 10 states: California, Minnesota, Arizona, Maine, Washington, Connecticut, Ohio, Wyoming, New Mexico and Tennessee.

Dmand AI lists angioplasty, aortic atherosclerois, atherosclerosis, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, chronic hypertension and chronic skin ulcer among the conditions Dr. Kadakia treats.

CMS data shows 1,580 Medicare services from Dr. Kadakia across 14 procedure codes in 2024, for 860 Medicare patients. Medicare paid $94,981 for them.

CMS counts 860 Medicare patients who saw Dr. Kadakia in 2024. The largest group is 65 to 74, with 317 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kadakia's median patient age at 61, with 48% women.

In 2024, Dr. Kadakia wrote 1,453 Medicare Part D claims for 424 patients. 84% of them were for generic drugs. CMS names the drug for 1,226 of them, across 28 drugs with 11 or more claims each, at $200,674 in total drug cost. In 2023, CMS named 426 claims across 19 drugs.

Dr. Kadakia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Kadakia, published from 2012 to 2014. The most frequent topics are Myocardial Infarction and Percutaneous Coronary Intervention. Dr. Kadakia's most frequent co-authors are Timothy D. Henry, MD, Daniel Lee Lips, MD and Thomas David Stuckey, MD.

CMS Open Payments shows 126 general payments to Dr. Kadakia from 17 drug and device companies from 2016 to 2025. Grants make up the largest share, 71% of the total. Boston Scientific Corporation paid the most, $15,394.

Dr. Kadakia graduated from Rural Medical College Pravara Institute of Medical Sciences in 1999. Dr. Kadakia is a member of ACC, ACP and HRS.

Dr. Kadakia is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.